BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This highly advanced multi-functional tracking formulation features cyanine 3 labeled liposomes co-loaded with doxorubicin and bleomycin. The structural matrix incorporates a precise molecular fraction of the hydrophobic fluorophore cyanine 3 (CY3) lipid tracking label within its bilayer shell, while simultaneously co-encapsulating the hydrophilic anthracycline doxorubicin and the glycopeptide antibiotic bleomycin entirely within its central aqueous core via active remote-loading parameters. This complex configuration coordinates sharp green-to-yellow optical fluorescence emission tracking parameters with a dual-phase multi-cargo model, establishing a highly consistent reference standard that completely prevents physical vesicle aggregation and restricts passive cargo leakage under ambient laboratory conditions.
Source
Custom synthesis
Functional Group
Cy3; Doxorubicin; Bleomycin
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.